JoinClinicalTrials.com

• A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

  NCT03649971

  Condition:   Adenomatous Polyposis Coli
  Interventions:   Drug: Guselkumab;   Drug: Placebo
  Sponsor:   Janssen Research & Development, LLC
  Recruiting
• Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

  NCT03806426

  Condition:   Familial Adenomatous Polyposis
  Interventions:   Drug: Eicosapentaenoic acid free fatty acid (EPA-FFA);   Drug: Placebo
  Sponsor:   S.L.A. Pharma AG
  Recruiting
• The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study

  NCT01725490

  Condition:   Familial Adenomatous Polyposis
  Interventions:   Drug: Metformin;   Drug: Placebo
  Sponsor:   Yonsei University
  Recruiting
• Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program

  NCT02747862

  Conditions:   Attenuated Familial Adenomatous Polyposis;   Deleterious Familial Adenomatous Polyposis
  Intervention:   Other: Chart Review
  Sponsor:   M.D. Anderson Cancer Center
  Recruiting
• Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis

  NCT03471403

  Condition:   Familial Adenomatous Polyposis
  Intervention:  
  Sponsor:   Western Sydney Local Health District
  Recruiting
• Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

  NCT02961374

  Conditions:   APC Gene Mutation;   Attenuated Familial Adenomatous Polyposis;   Familial Adenomatous Polyposis
  Interventions:   Drug: Erlotinib;   Drug: Erlotinib Hydrochloride
  Sponsor:   National Cancer Institute (NCI)
  Recruiting
• Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.

  NCT03061591

  Conditions:   Familial Adenomatous Polyposis;   FAP;   FAP Gene Mutation
  Interventions:   Dietary Supplement: Wholistic Turmeric capsules;   Other: Placebo
  Sponsor:   Tel-Aviv Sourasky Medical Center
  Not yet recruiting
• Endoscopic Evaluation of Duodenal Polyposis in Patients With Familial Adenomatous Polyposis (FAP)

  NCT03346980

  Conditions:   Familial Adenomatous Polyposes;   Duodenal Polyposis;   Duodenal Cancer
  Intervention:   Diagnostic Test: Esophagogastroduodenoscopy
  Sponsor:   Copenhagen University Hospital, Hvidovre
  Recruiting
• Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride

  NCT03333265

  Condition:   Colorectal Adenomas
  Interventions:   Drug: 100mg Berberine hydrochloride;   Drug: 300mg Berberine hydrochloride;   Drug: Placebo Oral Tablet
  Sponsor:   xiaohua li
  Recruiting
• Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics

  NCT03027401

  Conditions:   Neoplasms;   Adenomatous Polyposis Coli;   Neurofibroma, Plexiform;   Myelodysplastic Syndromes
  Intervention:  
  Sponsor:   National Cancer Institute (NCI)
  Not yet recruiting
• Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

  NCT02198092

  Conditions:   Familial Adenomatous Polyposis;   Map Syndrome;   Lynch Syndrome;   Hnpcc;   Colorectal Cancer
  Intervention:   Other: Epi proColon Testing
  Sponsors:   University of Pennsylvania;   Epigenomics, Inc
  Recruiting
• French Digestive Polyposis Cohorte Family Adenomatous Polyposis With APC and MYH Gene Mutations , Cowden's Disease With PTEN Gene Mutation, Peutz Jeghers Disease With STK 11 Gene Mutation ,juvénil Polyposis With SMAD 4 Gene Mutation , Serrated and Hyperplastic Polyposis

  NCT01987518

  Condition:   Quality of Life
  Interventions:   Other: Procedure surgery behavioral and genetic diagnosis;   Procedure: quality of life after different type of surgery
  Sponsor:   Hôpital Edouard Herriot
  Recruiting
• Familial Investigations of Childhood Cancer Predisposition

  NCT03050268

  Conditions:   Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
  Intervention:  
  Sponsor:   St. Jude Children's Research Hospital
  Recruiting
• Integrated Cancer Repository for Cancer Research

  NCT02012699

  Conditions:   Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breastcancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer
  Intervention:  
  Sponsor:   University of Nebraska
  Recruiting
• Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis

  NCT03966742

  Conditions:   Desmoid;   Desmoid Fibromatosis of Skin;   Desmoid Neoplasm of Chest Wall;   Desmoid Tumor Caused by Somatic Mutation;   Aggressive Fibromatoses;   Fibromatosis Desmoid;   Desmoid Fibromatosis
  Intervention:   Procedure: Drug Eluting Bead Embolization (DEB) for Desmoid Fibromatosis
  Sponsor:   Rabin Medical Center
  Recruiting
• MUTYH-associated Polyposis

  NCT03847532

  Condition:   MutYH-associated Polyposis
  Intervention:   Genetic: Sanger sequencing method
  Sponsor:   State Scientific Centre of Coloproctology, Russian Federation
  Recruiting